From the Super Bowl to the World Stage: What Health’s Cultural Moment Means Now

Super Bowl LX offered more than a strong showing for health and pharma brands. It signaled something more durable: health is no longer a category that waits for cultural permission. It’s actively shaping culture on the world’s biggest stages. That shift matters.
Roughly seven major health and pharma campaigns aired during the big game. But what stood out wasn’t volume. It was confidence. These brands claimed space alongside beer, cars, and tech.
More importantly, this moment shouldn’t be viewed in isolation. As we look ahead to the Olympics and the World Cup, we’re entering an extraordinary run of global tentpole moments where health, science, performance, access, and equity will increasingly intersect with culture at scale. Super Bowl LX was an early proof point.
What the strongest work got right
Across categories and geographies, the most effective campaigns shared three defining moves.
1. Stigma reduction through entertainment
Novartis used NFL tight ends to make prostate screening feel approachable, even funny, rather than fearful. Boehringer Ingelheim reframed early-detection testing as a “mission,” turning anxiety into agency. Humor and storytelling didn’t trivialize health; they unlocked attention, relatability, and permission.
2. Normalizing everyday health decisions
GLP-1 related ads put the focus on being human and positioned their treatment options as support and empowerment for patients, not intervention. These brands met people where they are. Not where the healthcare system wishes they were.
3. Cultural clarity
Simple metaphors. Human voices. Ideas that survived the post-game social conversation and shaped Monday-morning dialogue. The work that traveled didn’t over-explain science; it translated it.
The bigger signal
Industry and media reaction underscored a structural shift playing out globally: health is no longer purely clinical. It’s lifestyle-adjacent, values-driven, and culturally expressive. The brands that resonated weren’t just marketing products. They functioned as cultural facilitators, translating science into relevance, credibility, and permission. For trust-based, highly regulated categories, this is the difference between building confidence and eroding it.
Why this matters now
As health brands look ahead to the world’s next major cultural moments, the opportunity (and responsibility) is clear.
Cultural strategy and creative as core health capabilities
Brands need to enter culture without trivializing health, balancing regulatory rigor with entertainment and emotion. This requires earned-first thinking that travels across markets and moments.
Integrated moment marketing
Impact now lives across broadcast, social, earned media, influencers, and executive voice working together. The most effective programs build always-on platforms that culminate in tentpole moments, rather than relying on one-off activations.
Prevention and behavior-change storytelling
As healthcare moves upstream toward screening, early detection, and access, brands must reduce fear and inertia. That demands new creative frameworks that motivate action without alarm.
Corporate narrative alignment
Many of these campaigns carried implicit corporate messages around innovation, access, and equity. As scrutiny around healthcare ethics and pricing intensifies, alignment between brand, corporate, and leadership narratives becomes essential; not optional.
Looking ahead
Health is moving faster than many organizations are prepared to follow. The brands that succeed will be those that show up credibly, responsibly, and creatively. Not just during one event, but consistently across the world’s biggest cultural stages.
With the next Super Bowl less than a year away and the Olympics and World Cup on the horizon the window to plan thoughtfully is already open.
Jacob Porpossian is the Global Executive Creative Director for FleishmanHillard’s Health & Life Sciences practice, where he builds and leads creative and storytelling capabilities for major health brands. With a background spanning creative strategy, digital marketing, communications, and production, he advises integrated teams across healthcare, CPG, corporate, and technology sectors, while also championing diversity and inclusion initiatives across the agency and industry.


Bob Beasley is a senior vice president with FleishmanHillard’s B2B & Manufacturing practice. A former newspaper reporter, Bob has worked for more than 30 years helping people, communities and organizations tell stories with impact. Since joining FleishmanHillard in February 2007, Bob has provided communications counsel to some of the most respected companies in the world.

Matt Rose is the Americas Lead for Crisis, Issues & Risk Management. An SVP & Senior Partner in New York, he brings more than 30 years’ experience in advising organizations on crisis and issues management, risk mitigation, and reputation recovery. He has guided companies through reputational crises, labor issues, regulatory challenges, ESG controversies, and high-profile litigation.




Scott Radcliffe is FleishmanHillard’s global director of cybersecurity, leading the firm’s Cybersecurity Center of Excellence and advising clients on rising cyber risks. He recently rejoined FH from Apple, where he led cybersecurity communications and previously served as the agency’s senior global data privacy and security expert.




